The Daily Pulse

Business

Zero-Debt Firms Face High Market Valuations

Reported by Aditya Chauhan (Staff Writer) · Livemint - Markets ·

Unconfirmed — Reported by one source so far

Reported by one source so far

Important
Zero-Debt Firms Face High Market ValuationsPhoto: Wikimedia Commons

Strong balance sheets and zero debt make companies attractive, but expensive valuations leave little room for earnings mistakes. Five low-debt stocks are trading at high market prices.

Divi's Laboratories

Divi's Laboratories has a debt-to-equity ratio of zero. Its price-to-earnings multiple is 86, while the BSE Healthcare index trades at 42.3. Its price-to-book ratio is 13.6, which is higher than the sector ratio of 7.49. In the first quarter of fiscal year 2027, total income reached ₹31.44 billion, and profit after tax rose to ₹9.02 billion.

Trent

Trent, a Tata Group retail company, also has a debt-to-equity ratio of zero. The stock trades at a price-to-earnings multiple of 82.4, compared with 19.2 for the Nifty 50 index. Its price-to-book ratio is 20. In the first quarter, Trent reported revenue of ₹57.55 billion and a net profit of ₹5.18 billion.

SBI Life Insurance

SBI Life Insurance operates with a debt-free balance sheet and commands a high market premium over peers like HDFC Life Insurance and ICICI Prudential Life Insurance. In the first quarter of fiscal year 2027, new business premium rose 23% to ₹89.1 billion, and net profit grew 22% to ₹7.2 billion.

Context

Zero debt helps companies manage economic slowdowns without relying on heavy outside borrowing. However, paying high stock prices means investors expect fast profit growth in return.

Read more at Livemint - Markets →